RUNX3 and breast carcinoma: miR-210 participates in the proliferation of breast cancer cells, particularly triple-negative cells, and is related to lymph node metastases through targets such as CCND1 and RUNX3 (Khalilian et al., 2023; Santana et al., 2023).